Source: Contract Pharma

ChemPartner: ChemPartner Expands Biologics Capabilities

Makes additional investments in biologics from research to manufacturing capabilities

Read full article »
ChemPartner's Competitors | ChemPartner's News | ChemPartner's Financials
Stay up-to-date with the latest news on ChemPartner
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
CEO Avatar

CEO

Wei Tang

CEO Approval Rating

84/100

Read more
Stay up-to-date with the latest news on ChemPartner